Repeat Ivermectin Mass Drug Administrations for MALaria Control II

PHASE3CompletedINTERVENTIONAL
Enrollment

4,124

Participants

Timeline

Start Date

July 13, 2019

Primary Completion Date

November 8, 2020

Study Completion Date

August 1, 2024

Conditions
Malaria
Interventions
DRUG

Ivermectin

Ivermectin (6 mg tablet) given monthly from July-October each rainy season as a 3-day course of approximately 300 mcg/kg/day as estimated by height bands.

DRUG

Placebo oral tablet

placebo in the same size, color and shape at the ivermectin tablet

Trial Locations (1)

Unknown

Institut de Recherche en Sciences de la Sante, Diébougou

All Listed Sponsors
collaborator

Yale University

OTHER

collaborator

Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest

OTHER_GOV

collaborator

Radboud University Medical Center

OTHER

collaborator

PATH

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Brian Foy

OTHER

NCT03967054 - Repeat Ivermectin Mass Drug Administrations for MALaria Control II | Biotech Hunter | Biotech Hunter